AC T10358
XX
ID T10358
XX
DT 10.03.2005 (created); nvo.
DT 08.01.2014 (updated); yre.
CO Copyright (C), QIAGEN.
XX
FA HMGIY
XX
SY High Mobility Group protein I(Y).
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
CP MCF-7, HBL-100, MDA-MB-453, BT-549, BT-20, MDA-MB-436, SK-BR-3, MDA-MB-231, MDA-MB-361 [10].
CN H-MEC, T47D [10].
XX
IN T10504 AP-2alpha; Mammalia.
IN T09410 C/EBPbeta; Mammalia.
IN T14816 IRF-1; Mammalia.
IN T10361 Oct-2; Mammalia.
IN T14054 PARP; human, Homo sapiens.
IN T08628 POU2F1; Mammalia.
IN T10397 RelA-p65; Mammalia.
IN T08326 Sp1; Mammalia.
XX
MX M01653 V$HMGIY_01.
MX M01010 V$HMGIY_Q3.
MX M07320 V$HMGIY_Q3_01.
MX M01879 V$HMGIY_Q4.
MX M00750 V$HMGIY_Q6.
XX
BS R23098.
BS R00918.
BS R00920.
BS R14721.
BS R14727.
BS R24896.
BS R24897.
BS R40756.
BS R40757.
BS R21639.
BS R24860.
BS R22927.
BS R22928.
BS R20851.
BS R20869.
BS R20870.
BS R20871.
BS R20873.
BS R20878.
BS R34590.
BS R34591.
BS R34592.
BS R34593.
BS R34594.
BS R34595.
BS R34596.
BS R34597.
BS R34598.
BS R34599.
BS R34600.
BS R34601.
BS R34602.
BS R11552.
BS R73896.
BS R73897.
BS R73898.
BS R34504.
BS R34630.
BS R34503.
BS R05081.
BS R08132.
BS R34527.
XX
DR TRANSPATH: MO000047790.
DR TRANSCOMPEL: C00056.
DR TRANSCOMPEL: C00057.
DR TRANSCOMPEL: C00058.
DR TRANSCOMPEL: C00059.
DR TRANSCOMPEL: C00092.
DR TRANSCOMPEL: C00093.
DR TRANSCOMPEL: C00094.
DR TRANSCOMPEL: C00167.
DR TRANSCOMPEL: C00329.
XX
RN [1]; RE0013040.
RX PUBMED: 8816451.
RA French S. W., Schmidt M. C., Glorioso J. C.
RT Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2
RL Mol. Cell. Biol. 16:5393-5399 (1996).
RN [2]; RE0014852.
RX PUBMED: 10582687.
RA Liu W.-M., Guerra-Vladusic F. K., Kurakata S., Lupu R., Kohwi-Shigematsu T.
RT HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype
RL Cancer Res. 59:5695-5703 (1999).
RN [3]; RE0024011.
RX PUBMED: 10357819.
RA Yie J., Merika M., Munshi N., Chen G., Thanos D.
RT The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
RL EMBO J. 18:3074-3089 (1999).
RN [4]; RE0031776.
RX PUBMED: 10617144.
RA Xiao D. M., Pak J. H., Wang X., Sato T., Huang F. L., Chen H. C., Huang K. P.
RT Phosphorylation of HMG-I by protein kinase C attenuates its binding affinity to the promoter regions of protein kinase C gamma and neurogranin/RC3 genes.
RL J. Neurochem 74:392-9 (2000).
RN [5]; RE0038243.
RX PUBMED: 11056164.
RA Pellacani A., Wiesel P., Razavi S., Vasilj V., Feinberg M. W., Chin M. T., Reeves R., Perrella M. A.
RT Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-beta 1
RL J. Biol. Chem. 276:1653-1659 (2001).
RN [6]; RE0038420.
RX PUBMED: 10713105.
RA Fedele M., Benvenuto G., Pero R., Majello B., Battista S., Lembo F., Vollono E., Day P. M., Santoro M., Lania L., Bruni C. B., Fusco A., Chiariotti L.
RT A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor
RL J. Biol. Chem. 275:7894-901 (2000).
RN [7]; RE0044908.
RX PUBMED: 15162382.
RA Takaha N., Resar L. M., Vindivich D., Coffey D. S.
RT High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells
RL Prostate 60:160-7 (2004).
RN [8]; RE0047952.
RX PUBMED: 9823775.
RA Abdulkadir S. A., Casolaro V., Tai A. K., Thanos D., Ono S. J.
RT High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
RL J. Leukoc. Biol. 64:681-691 (1998).
RN [9]; RE0049828.
RX PUBMED: 16204234.
RA Hassa P. O., Haenni S. S., Buerki C., Meier N. I., Lane W. S., Owen H., Gersbach M., Imhof R., Hottiger M. O.
RT Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription.
RL J. Biol. Chem. 280:40450-40464 (2005).
RN [10]; RE0051834.
RX PUBMED: 12640109.
RA Baldassarre G., Battista S., Belletti B., Thakur S., Pentimalli F., Trapasso F., Fedele M., Pierantoni G., Croce C. M., Fusco A.
RT Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.
RL Mol. Cell. Biol. 23:2225-2238 (2003).
RN [11]; RE0053460.
RX PUBMED: 16707431.
RA Paonessa F., Foti D., Costa V., Chiefari E., Brunetti G., Leone F., Luciano F., Wu F., Lee A. S., Gulletta E., Fusco A., Brunetti A.
RT Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer.
RL Cancer Res. 66:5085-5093 (2006).
XX
//